Relative vaccine effectiveness (rVE) of mRNA COVID-19 boosters in people aged at least 75 years in the UK vaccination programme, during the Spring-Summer (monovalent vaccine) and Autumn-Winter 2022 (bivalent vaccine) booster campaigns: a prospective test negative case-control study

Anastasia Chatzilena; Catherine Hyams; Rob Challen; Robin Marlow; Jade King; David Adegbite; Jane Kinney; Madeleine Clout; Nick Maskell; Jennifer Oliver; Adam Finn; Leon Danon

doi:10.1101/2023.03.16.23287360

Relative vaccine effectiveness (rVE) of mRNA COVID-19 boosters in people aged at least 75 years in the UK vaccination programme, during the Spring-Summer (monovalent vaccine) and Autumn-Winter 2022 (bivalent vaccine) booster campaigns: a prospective test negative case-control study

Anastasia Chatzilena, Catherine Hyams, Rob Challen, Robin Marlow, Jade King, David Adegbite, Jane Kinney, Madeleine Clout, Nick Maskell, Jennifer Oliver, Adam Finn, Leon Danon

Research output: Other contribution

Original language	Undefined/Unknown
DOIs	https://doi.org/10.1101/2023.03.16.23287360
Publication status	Published - 17 Mar 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Groups and Themes

Academic Respiratory Unit

Access to Document

10.1101/2023.03.16.23287360

Handle.net

Persistent link

Cite this

Chatzilena, A., Hyams, C., Challen, R., Marlow, R., King, J., Adegbite, D., Kinney, J., Clout, M., Maskell, N., Oliver, J., Finn, A., & Danon, L. (2023, Mar 17). Relative vaccine effectiveness (rVE) of mRNA COVID-19 boosters in people aged at least 75 years in the UK vaccination programme, during the Spring-Summer (monovalent vaccine) and Autumn-Winter 2022 (bivalent vaccine) booster campaigns: a prospective test negative case-control study. https://doi.org/10.1101/2023.03.16.23287360

@misc{0741e276e998496aaea5c0751d83e2a7,

title = "Relative vaccine effectiveness (rVE) of mRNA COVID-19 boosters in people aged at least 75 years in the UK vaccination programme, during the Spring-Summer (monovalent vaccine) and Autumn-Winter 2022 (bivalent vaccine) booster campaigns: a prospective test negative case-control study",

author = "Anastasia Chatzilena and Catherine Hyams and Rob Challen and Robin Marlow and Jade King and David Adegbite and Jane Kinney and Madeleine Clout and Nick Maskell and Jennifer Oliver and Adam Finn and Leon Danon",

year = "2023",

month = mar,

day = "17",

doi = "10.1101/2023.03.16.23287360",

language = "Undefined/Unknown",

type = "Other",

}

Chatzilena, A , Hyams, C, Challen, R, Marlow, R, King, J, Adegbite, D, Kinney, J, Clout, M, Maskell, N, Oliver, J, Finn, A & Danon, L 2023, Relative vaccine effectiveness (rVE) of mRNA COVID-19 boosters in people aged at least 75 years in the UK vaccination programme, during the Spring-Summer (monovalent vaccine) and Autumn-Winter 2022 (bivalent vaccine) booster campaigns: a prospective test negative case-control study. https://doi.org/10.1101/2023.03.16.23287360

Relative vaccine effectiveness (rVE) of mRNA COVID-19 boosters in people aged at least 75 years in the UK vaccination programme, during the Spring-Summer (monovalent vaccine) and Autumn-Winter 2022 (bivalent vaccine) booster campaigns: a prospective test negative case-control study. / Chatzilena, Anastasia ; Hyams, Catherine; Challen, Rob et al.
2023.

Research output: Other contribution

TY - GEN

T1 - Relative vaccine effectiveness (rVE) of mRNA COVID-19 boosters in people aged at least 75 years in the UK vaccination programme, during the Spring-Summer (monovalent vaccine) and Autumn-Winter 2022 (bivalent vaccine) booster campaigns: a prospective test negative case-control study

AU - Chatzilena, Anastasia

AU - Hyams, Catherine

AU - Challen, Rob

AU - Marlow, Robin

AU - King, Jade

AU - Adegbite, David

AU - Kinney, Jane

AU - Clout, Madeleine

AU - Maskell, Nick

AU - Oliver, Jennifer

AU - Finn, Adam

AU - Danon, Leon

PY - 2023/3/17

Y1 - 2023/3/17

UR - https://doi.org/10.1101/2023.03.16.23287360

U2 - 10.1101/2023.03.16.23287360

DO - 10.1101/2023.03.16.23287360

M3 - Other contribution

ER -

Chatzilena A , Hyams C, Challen R, Marlow R, King J, Adegbite D et al. Relative vaccine effectiveness (rVE) of mRNA COVID-19 boosters in people aged at least 75 years in the UK vaccination programme, during the Spring-Summer (monovalent vaccine) and Autumn-Winter 2022 (bivalent vaccine) booster campaigns: a prospective test negative case-control study. 2023. doi: 10.1101/2023.03.16.23287360

Relative vaccine effectiveness (rVE) of mRNA COVID-19 boosters in people aged at least 75 years in the UK vaccination programme, during the Spring-Summer (monovalent vaccine) and Autumn-Winter 2022 (bivalent vaccine) booster campaigns: a prospective test negative case-control study

UN SDGs

Research Groups and Themes

Access to Document

Handle.net

Other files and links

Cite this